Skip to main content

How Egypt became hub for Russian COVID-19 vaccine

Egypt may become the hub of coronavirus vaccines in Africa after it agreed to produce the Russian Sputnik-V vaccine against the coronavirus.

GettyImages-1229950039.jpg
A nurse shows the Sputnik V (Gam-COVID-Vac) vaccine against the coronavirus disease (COVID-19) at a clinic in Moscow on December 5, 2020, amid the ongoing coronavirus disease pandemic. - Russian President has told authorities to begin "large-scale" vaccinations among at-risk populations. The drugs should be made generally available to the Russian public in early 2021. — KIRILL KUDRYAVTSEV/AFP via Getty Images

CAIRO — Chief executive officer at Russian Direct Investment Fund (RDIF) Kirill Dmitriev recently said there is a possibility that Russia could begin production of its Sputnik V coronavirus vaccine in Egypt and Algeria.

Speaking at an online UN session to present the Russian vaccine Dec. 2, Dmitriev said more than 40 countries — involving more than 50% of the global population — expressed interest in the Sputnik vaccine. He noted that RDIF received requests for the production of more than 1.2 billion doses of the vaccine, adding that the price of the dose is less than $10 — which makes it the least expensive coronavirus vaccine developed in the world to date.

During a teleconference with members of his government Aug. 11, Russian President Vladimir Putin said that Russia has become the first country in the world to formally approve a coronavirus vaccine following the necessary trials, and one of his daughters has already been inoculated.

Although it was approved in Russia as the first effective vaccine against the coronavirus, the World Health Organization (WHO) has yet to register Sputnik-V.

SUBSCRIBER EXCLUSIVE

Continue reading this exclusive analysis

Original reporting and analysis unavailable elsewhere. Subscribe to AL-MONITOR to read this story and access everything we publish